Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

CEO appointment and Board changes

12 May 2022 07:15

RNS Number : 1833L
Plant Health Care PLC
12 May 2022
 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

CEO appointment and Board changes

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce the appointment of a new Chief Executive Officer and consequent changes to the Board.

 

Highlights

 

· Jeff Tweedy, currently the Company's Chief Operating Officer, will be appointed Chief Executive Officer (CEO) with effect from the Annual General Meeting on June 22nd, 2022

· At the same time, Chris Richards, currently CEO, will be appointed Non-Executive Chairman of the Board and Richard Webb, currently Non-Executive Chairman, will step down from the Board. 

 

Chris Richards stepped in as CEO in November 2017, having previously been Chairman since August 2012. By appointing Chris to the role of Non-Executive Chairman, the Company continues to benefit from his deep experience. At the same time, Richard Webb, currently Non-Executive Chairman, will step down from the Board to pursue other interests.

 

Chris Richards, CEO of Plant Health Care said, ‟I am delighted with the appointment of Jeff Tweedy as my successor, in line with our long-established succession plan. Jeff has delivered consistent and exceptional performance as COO and has earned the respect of both internal and external stakeholders. He is the perfect person to lead the company into its exciting next phase of growth. It will be an honour to support Jeff in his new role, where I have no doubt that his energy, commitment and professionalism will deliver continued success for Plant Health Care over the coming years. 

 

"On behalf of the entire Board, I would like to express our most heartfelt thanks to Richard Webb. Richard was instrumental in the early strategic development of the company, especially in working with Dr Zhongmin Wei on the research which has delivered the enormously exciting PREtec product pipeline. As such, Richard has made an incomparable contribution to the Company. We wish him every success in his new endeavours."

 

Background

Jeff Tweedy joined Plant Health Care in October 2017 as Commercial Head for North America, then promoted to Global Head of Commercial in 2020. He was then appointed Chief Operating Officer of Plant Health Care and a member of the Board of Directors in November 2019. Jeff has progressively taken on more responsibilities and discharged them with great success. Over the last 18 months, he has led most of the day-to-day operations of the Company. Under Jeff's leadership, the Company has delivered robust financial performance and successfully brought forward the exceptionally promising PREtec ('Vaccines for Plants') product pipeline. In light of this performance, the Board unanimously agreed to appoint Jeff as Chief Executive Officer of Plant Health Care (CEO), with effect from the end of the Annual General Meeting on June 22nd, 2022.

 

With effect from June 22nd, Jeff Tweedy will be responsible for running the Company. Chris Richards will be available to mentor Jeff and to provide support for corporate development and investor relations.

 

Richard Webb has been a valued member of the Board since 2013 and has made an invaluable contribution to the Company's strategy, especially in supporting the discovery and development of PREtec.

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information, please contact:

 

Plant Health Care plc

 

Jeff Hovey, CFO

+1 919 926 1600

Cenkos Securities plc - Nomad and Broker

 

Neil McDonald / Peter Lynch

+44 (0) 20 7391 8900

Vox Markets - Digital Investor Relations

 

Paul Cornelius / Kat Perez

+44 (0) 7866 384707

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAABMRTMTJBBBT
Date   Source Headline
20th Apr 20227:00 amRNSHolding(s) in Company
19th Apr 20221:46 pmRNSNotice of results and investor presentation
11th Apr 202212:52 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNew Distribution agreement with Ager Agro
14th Mar 202212:49 pmRNSHolding(s) in Company
11th Mar 202212:19 pmRNSHolding(s) in Company
3rd Feb 202212:56 pmRNSHolding(s) in Company
1st Feb 20221:16 pmEQSPlant Health Care, plc
1st Feb 20227:00 amRNS2021 Trading Statement
31st Jan 20227:00 amRNSPHC949 product registration submitted to the EPA
17th Jan 20227:00 amRNSInvestor Presentation
15th Dec 20217:00 amRNSWilbur Ellis and Plant Health Care discussion
13th Dec 20217:00 amRNSCommercial scale manufacturer for Saori
30th Nov 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20216:03 pmRNSExercise of Options
22nd Sep 20217:00 amRNSNew agreement with Nutrien for Saori launch
22nd Sep 20217:00 amRNSInterim Report 30 June 2021
21st Sep 20214:41 pmRNSSecond Price Monitoring Extn
21st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSArgentina approves Harpin as a seed treatment
24th Aug 20217:00 amRNSInvestor Presentation
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:36 pmRNSPrice Monitoring Extension
9th Aug 20211:27 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSAdmission to the U.S. OTCQB Venture Market
27th Jul 20217:00 amRNSNew Distribution Agreement with Agrii UK
26th Jul 20217:00 amRNS2021 Half-Year Trading Statement
23rd Jul 20217:00 amRNSGrant of Options
22nd Jul 20217:00 amRNSInvestor Presentation
12th Jul 20214:40 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20212:33 pmRNSResult of AGM
14th Jun 20217:00 amRNSGreen Economy Mark awarded
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSInvestor Presentation
7th May 20213:50 pmRNSAnnual Report & Accounts and AGM Notice Published
30th Apr 20215:40 pmRNSHolding(s) in Company
23rd Apr 20217:00 amRNSResults for the year ended 31 December 2020
21st Apr 202111:58 amRNSHolding(s) in Company
8th Apr 20213:30 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
22nd Mar 20217:00 amRNSInvestor Presentation
18th Mar 20211:57 pmRNSResults of Placing and Subscription
18th Mar 20217:00 amRNSProposed Placing and Subscription
1st Mar 20217:00 amRNSSaori Trial Update
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.